I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 26% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 19% ± 4% | |
| natural killer cell | 6 studies | 21% ± 4% | |
| classical monocyte | 5 studies | 24% ± 8% | |
| epithelial cell | 5 studies | 33% ± 14% | |
| endothelial cell of vascular tree | 5 studies | 20% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 2% | |
| smooth muscle cell | 4 studies | 22% ± 3% | |
| ciliated cell | 4 studies | 26% ± 6% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| B cell | 3 studies | 21% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 6% | |
| conventional dendritic cell | 3 studies | 28% ± 10% | |
| non-classical monocyte | 3 studies | 30% ± 8% | |
| pericyte | 3 studies | 20% ± 3% | |
| fibroblast | 3 studies | 23% ± 5% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 2% |
